Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ASPIRE: Adult SPasticity International REgistry on BOTOX® Treatment

Trial Profile

ASPIRE: Adult SPasticity International REgistry on BOTOX® Treatment

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Feb 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Muscle spasticity
  • Focus Therapeutic Use
  • Acronyms ASPIRE
  • Sponsors Allergan
  • Most Recent Events

    • 12 Oct 2018 Results examining onabotulinumtoxinA utilization and effectiveness to treat spasticity in multiple sclerosis (MS) patients presented at the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
    • 27 Apr 2018 One year interim results from ASPIRE trial presented at the 70th Annual Meeting of the American Academy of Neurology
    • 11 Oct 2017 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top